Falvo Laura, Catania Antonio, D'Andrea Vito, Marzullo Antonella, Giustiniani Maria Cristina, De Antoni Enrico
Division of General Surgery, Department of Surgical Sciences 3rd training program in General Surgery, La Sapienza, University of Rome, Italy.
Ann Surg. 2005 Apr;241(4):640-6. doi: 10.1097/01.sla.0000157317.60536.08.
To conduct a retrospective study of 39 patients with papillary carcinoma of the thyroid with histologic vascular invasion (VI+) and 361 patients without any sign of vascular invasion (VI-).
In the present study, we undertook a retrospective analysis of papillary carcinoma of the thyroid to assess whether histologically determined vascular invasion can be considered a predictive factor for prognosis.
By means of a retrospective study, we evaluated the department's database of patients with papillary thyroid carcinoma who had undergone total thyroidectomy from January 1993 to December 1999.
Group I consisted of papillary carcinoma without any sign of vascular invasion (VI-) comprising 361 patients. Group II consisted of papillary carcinoma with vascular invasion (VI+) comprising 39 patients. At the time of diagnosis, we observed no metastases in patients with VI-, whereas a pulmonary metastasis was observed in 1 patient with VI+ (P = 0.0023). In 3.6% patients with VI- and in 20.5% patients with VI+, we observed recurrences in the regional lymph nodes (P < 0.001); we observed 6 (1.66%) distant metastases in patients with VI- and in the 12.8% patients with VI+ (P < 0.001). Three patients with VI+ (7.7%) and 2 patients with VI- (0.6%) died of tumor-related causes; these figures were found to be statistically significant (P < 0.001).
In papillary carcinoma, it should be noted that histologic vascular invasion may be considered as a sign of an increased tendency toward hematogenic invasion and consequent increase in the relative percentage of metastases; ultimately, this means a poorer prognosis. In the presence of risk factors indicating a possible increase in biologic aggressiveness, adequate postoperative treatment and close follow up become essential.
对39例伴有组织学血管侵犯(VI+)的甲状腺乳头状癌患者和361例无任何血管侵犯迹象(VI-)的患者进行回顾性研究。
在本研究中,我们对甲状腺乳头状癌进行了回顾性分析,以评估组织学确定的血管侵犯是否可被视为预后的预测因素。
通过回顾性研究,我们评估了该科室1993年1月至1999年12月期间接受全甲状腺切除术的甲状腺乳头状癌患者数据库。
第一组由无任何血管侵犯迹象(VI-)的乳头状癌组成,共361例患者。第二组由伴有血管侵犯(VI+)的乳头状癌组成,共39例患者。在诊断时,我们观察到VI-患者无转移,而1例VI+患者出现肺转移(P = 0.0023)。在3.6%的VI-患者和20.5%的VI+患者中,我们观察到区域淋巴结复发(P < 0.001);我们观察到VI-患者中有6例(1.66%)发生远处转移,VI+患者中有12.8%发生远处转移(P < 0.001)。3例VI+患者(7.7%)和2例VI-患者(0.6%)死于肿瘤相关原因;这些数字具有统计学意义(P < 0.001)。
在乳头状癌中,应注意组织学血管侵犯可能被视为血行侵犯倾向增加以及转移相对百分比增加的标志;最终,这意味着预后较差。在存在表明生物学侵袭性可能增加的危险因素时,充分的术后治疗和密切随访至关重要。